Skip to main content

Revision Bulletins

Revision Bulletins are published in USP–NF Online by the first of each month. Each Revision Bulletin includes a notice that provides the reason for the change and the official date. Monograph names listed before April 1, 2021 contain a combined notice and documentary standard; postings after April 1, 2021 provide separate links for the notice and for the standard content. For more information on the Revision Bulletins and the Accelerated Revision process, see USP's Guideline on the Use of Accelerated Processes for Revisions to USP–NF. Archived Revision Bulletins can be found here.

See the Publication & Comment Schedule section for specific posting and official dates.

New and Updated Revision Bulletins

  • Baclofen Injection Notice and Monograph (posted 19–Nov–2021; official 01–Dec–2021)
  • Dextrose Injection Notice and Monograph (posted 19–Nov–2021; official 01–Jun–2022)
  • Magnesia Tablets Notice and Monograph (posted 19–Nov–2021; official 01–Dec–2022)
  • Magnesium Carbonate Notice and Monograph (posted 19–Nov–2021; official 01–Dec–2022)
  • Magnesium Hydroxide Notice and Monograph (posted 19–Nov–2021; official 01–Dec–2022)
  • Magnesium Hydroxide Paste Notice and Monograph (posted 19–Nov–2021; official 01–Dec–2022)
  • Magnesium Oxide Notice and Monograph (posted 19–Nov–2021; official 01–Dec–2022)
  • Magnesium Trisilicate Notice and Monograph (posted 19–Nov–2021; official 01–Dec–2022)
  • Metformin Hydrochloride Extended-Release Tablets Notice and Monograph (posted 19–Nov–2021; official 01–Dec–2021)
  • Milk of Magnesia Notice and Monograph (posted 19–Nov–2021; official 01–Dec–2022) 
  • Quetiapine Extended-Release Tablets Notice and Monograph (posted 19–Nov–2021; official 01–Dec–2021)
  • Starch TS Notice and Monograph (posted 19–Nov–2021; official 01–Dec–2021)
  • Chlordiazepoxide Hydrochloride and Clidinium Bromide Capsules Notice and Monograph (posted 04–Nov–2021; official 05–Nov–2021)
    • Previously published as a Pending Notice of Intent to Revise
  • Dexamethasone Tablets Notice and Monograph (posted 02–Nov–2021; official 03–Nov–2021)
    • Previously published as a Pending Notice of Intent to Revise
  • Acetaminophen Oral Suspension Notice and Monograph (posted 29–Oct–2021; official 01–Nov–2021)
  • Alprazolam Tablets Notice and Monograph (posted 29–Oct–2021; official 01–Nov–2021)
  • Amoxicillin Capsules Notice and Monograph (posted 29–Oct–2021; official 01–Nov–2021)
  • Amoxicillin Tablets Notice and Monograph (posted 29–Oct–2021; official 01–Nov–2021)
  • Bupropion Hydrochloride Extended-Release Tablets Notice and Monograph (posted 29–Oct–2021; official 01–Nov–2021
  • Diphenhydramine Hydrochloride Capsules Notice and Monograph (posted 29–Oct–2021; official 01–Nov–2021)
  • Diphenhydramine Hydrochloride Oral Solution Notice and Monograph (posted 29–Oct–2021; official 01–Nov–2021)
  • Diphenhydramine and Phenylephrine Hydrochlorides Tablets Notice and Monograph (posted 29–Oct–2021; official 01–Nov–2021)
  • Divalproex Sodium Delayed-Release Capsules Notice and Monograph (posted 29–Oct–2021; official 01–Nov–2021)
  • Glycine Notice and Monograph (posted 29–Oct–2021; official 01–Nov–2021)
  • Phenylephrine Hydrochloride Tablets Notice and Monograph (posted 29–Oct–2021; official 01–Nov–2021)
  • Rotigotine Notice and Monograph (posted 29–Oct–2021; official 01–Nov–2021)
  • Quinidine Gluconate Extended-Release Tablets Notice and Monograph (posted 07–Oct–2021; official 08–Oct–2021)
    • Previously published as a Pending Notice of Intent to Revise
  • Metformin Hydrochloride Extended-Release Tablets Notice and Monograph (posted 16–Sep–2021; official 17–Sep–2021)
    • Previously published as a Pending Notice of Intent to Revise
  • Quetiapine Extended-Release Tablets Notice and Monograph (posted 27–Aug–2021; official 01–Sep–2021)
  • Tranexamic Acid Tablets Notice and Monograph (posted 27–Aug–2021; official 01–Sep–2021)

Revision Bulletins

To view Accelerated Revisions by official date, please click here.